Companies
Raymond James lifts InVivo Therapeutics Holdings Corp [NVIV] price estimate. Who else is bullish?
InVivo Therapeutics Holdings Corp [NASDAQ: NVIV] closed the trading session at $0.53. The company report on March 9, 2023 at 8:55 AM that InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury. Study did not achieve primary endpoint of
